Infection  >>  Vanihep (vaniprevir)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vanihep (vaniprevir) / Merck (MSD)
MK-7009-044, NCT01405937: Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment

Completed
3
51
NA
vaniprevir, MK-7009, peg-IFN, PegIntron®, ribavirin, REBETOL®
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
02/13
03/13
MK-7009-045, NCT01405560: Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment

Completed
3
42
NA
Vaniprevir, MK-7009, peg-IFN, PegIntron, ribavirin, REBETOL®
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
03/13
03/13
MK-7009-043, NCT01370642: Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants

Completed
3
294
NA
vaniprevir, MK-7009, Placebo to vaniprevir, Peg-IFN, PegIntron, ribavirin, REBETOL®
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
07/13
03/14

Download Options